RecruitingNot ApplicableNCT07092059

Smartphone Services for Stimulant Use Disorder

Decentralized Clinical Trial of Contingency Management Digital Therapeutic to Treat Stimulant Use Disorder


Sponsor

DynamiCare Health

Enrollment

270 participants

Start Date

Jun 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Adults who are at least 18 years old, speak/read English, have a smartphone, and who meet criteria for Stimulant Use Disorder, active or early remission. If being discharged to outpatient or intensive outpatient care, the patient is eligible.

Exclusion Criteria2

  • Unwilling to authorize communication with any treatment provider(s), requiring acute detoxification from alcohol or opioids or residential or hospital treatment, or other obstacle to longitudinal participation in the study.
  • Currently pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESmartphone digital therapeutic system

This intervention is composed of a smartphone app (Apple iOS or Android type) that prompts patients with Stimulant Use Disorder to (1) complete self-assessment questionnaires in the app about their health, health care needs and the services they receive and other health-related functions in life, (2) read educational modules about health and wellness and answer questions about these readings, (3) speak periodically with a Guide about their use of the app, and (4) take periodic saliva substance tests using video-selfies with their smartphone camera. The intervention includes testing and interviews with the study staff over a 12 month period. There is a follow-up period to measure the longer-term results at 15 months, as well.


Locations(1)

This is an At-Home Study - no travel or on-site visits are needed at all; Main Office: 6 Liberty Sq, #2102

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07092059


Related Trials